Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Herpes Simplex Virus Type 2 (HSV2) antibody (FITC)

HSV2 Reactivity: Herpes Simplex Virus (HSV) IF Host: Sheep Polyclonal FITC
Catalog No. ABIN112737
  • Target
    Herpes Simplex Virus Type 2 (HSV2)
    Reactivity
    • 25
    • 6
    • 6
    • 2
    • 1
    Herpes Simplex Virus (HSV)
    Host
    • 24
    • 13
    • 1
    Sheep
    Clonality
    • 24
    • 13
    Polyclonal
    Conjugate
    • 21
    • 7
    • 5
    • 4
    • 1
    FITC
    Application
    • 25
    • 24
    • 20
    • 7
    • 6
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (IF)
    Immunogen
    HSV type 2, strain G (human)
  • Application Notes
    Suitable for use in ELISA, direct IFA and Western blot.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    4-5 mg/mL (OD280 nm, E0.1% = 1.4)
    Buffer
    0.01 M PBS, pH 7.2 containing 10 mg/mL BSA as stabilizer and 0.09 % Sodium azide as preservative.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C/-20 °C
    Storage Comment
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Should this product contain a precipitate we recommend microcentrifugation before use.
  • Target
    Herpes Simplex Virus Type 2 (HSV2)
    Alternative Name
    Herpes Simplex Virus 2 / HSV2
    Target Type
    Virus
    Background
    Herpes simplex type 2 (HSV2) belongs to a family that includes HSV1, Epstein-Barr virus (EBV) and Varicella zoster (chicken pox) virus. HSV1 and HSV2 are extremely difficult to distinguish from each other. These viruses have a DNA genome, an icosahedral protein coat and are encased in a lipid membrane derived from the nuclear membrane of the last host. These viruses are capable of entering a latent phase where the host shows no visible sign of infection and levels of infectious agent become very low. During the latent phase the viral DNA is integrated into the genome of the host cell.Synonyms: HHV2
You are here:
Support